UDIV-B:CA:TSX-Manulife Smart U.S. Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 14.7

Change

-0.12 (-0.81)%

Market Cap

CAD 0.10B

Volume

3.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.01 (-0.04%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.06 (+0.18%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

+0.12 (+0.59%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.06 (+0.16%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.09 (+0.20%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.07 (-0.70%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.01%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.03 (-0.13%)

CAD 2.78B

ETFs Containing UDIV-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.34% 52% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.34% 52% F 46% F
Trailing 12 Months  
Capital Gain 17.13% 64% D 63% D
Dividend Return 2.08% 38% F 26% F
Total Return 19.21% 63% D 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.44% 58% F 49% F
Dividend Return 4.63% 57% F 44% F
Total Return 0.20% 45% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 7.88% 63% D 81% B-
Risk Adjusted Return 58.81% 74% C 70% C-
Market Capitalization 0.10B 62% D 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.